At #AACR26, Dr. Ranjan Upadhyay presented results of a Phase 2 trial of hormone receptor positive inflammatory breast cancer. The study showed that detecting cDNA can precede radiographic relapse by up to 15 months, indicating a potential window for intervention. Learn more: